These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1959497)

  • 1. [Value of prazepam drops in the brief treatment of anxiety disorders].
    Ansseau M; Von Frenckell R
    Encephale; 1991; 17(4):291-4. PubMed ID: 1959497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care].
    Chabannes JP; Lemoine P
    Therapie; 1990; 45(6):467-70. PubMed ID: 2080484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
    Dorman T
    Pharmatherapeutica; 1983; 3(6):433-40. PubMed ID: 6353434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety].
    Guelfi JD; Lancrenon S; Millet V
    Encephale; 1993; 19(5):547-52. PubMed ID: 8306923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients.
    Saletu M; Saletu B; Grünberger J; Mader R; Karobath M
    Neuropsychobiology; 1983; 9(2-3):119-34. PubMed ID: 6353268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepam.
    Ansseau M; Doumont A; von Frenckell R; Collard J
    Psychopharmacology (Berl); 1984; 84(3):293-8. PubMed ID: 6151206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation.
    Weir JH
    J Clin Psychiatry; 1978 Dec; 39(12):841-7. PubMed ID: 721788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of hydroxyzine in generalized anxiety disorder: controlled double-blind study versus placebo].
    Ferreri M; Hantouche EG; Billardon M
    Encephale; 1994; 20(6):785-91. PubMed ID: 7875114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective short-term treatment of generalized anxiety disorder with trifluoperazine.
    Mendels J; Krajewski TF; Huffer V; Taylor RJ; Secunda S; Schless A; Sebastian JA; Semchyshyn G; Durr MJ; Melmed AS
    J Clin Psychiatry; 1986 Apr; 47(4):170-4. PubMed ID: 3514583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW; Daniel JT; King RE; Moore DT
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.